Cargando…
Chimeric antigen receptor preparation from hybridoma to T-cell expression
The successful use of chimeric antigen receptor (CAR) for hematological cancer treatment has influenced the direction taken in translational research toward an increasing focus on personalized targeted immunotherapy. Thus, a growing number of labs worldwide are now interested in testing their old an...
Autores principales: | Köksal, Hakan, Baken, Elizabeth, Warren, David John, Løset, Geir Åge, Inderberg, Else Marit, Wälchli, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990154/ https://www.ncbi.nlm.nih.gov/pubmed/33928223 http://dx.doi.org/10.1093/abt/tbz007 |
Ejemplares similares
-
A TCR-based Chimeric Antigen Receptor
por: Walseng, Even, et al.
Publicado: (2017) -
Colorectal cysts as a validating tool for CAR therapy
por: Dillard, Pierre, et al.
Publicado: (2020) -
Efficient chimeric antigen receptor targeting of a central epitope of CD22
por: Casey, Nicholas Paul, et al.
Publicado: (2023) -
Sympathetic improvement of cancer vaccine efficacy
por: Inderberg, Else Marit, et al.
Publicado: (2020) -
Long-term surviving cancer patients as a source of therapeutic TCR
por: Inderberg, Else Marit, et al.
Publicado: (2020)